Institutional Ownership
Harvard Bioscience Inc
CUSIP 416906105COMHBIOQ1 2026
13D / 13G Filings
43
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
9.8%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
43 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Leviticus Partners LP | 13G/A | 7.6% | 3.40M | SEC |
| 2 | Nov 3, 2025 | Leviticus Partners LP | 13G/A | 7.5% | 3.35M | SEC |
| 3 | Aug 7, 2025 | Leviticus Partners LP | 13G/A | 9.2% | 4.05M | SEC |
| 4 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 2.5% | 1.11M | SEC |
| 5 | May 30, 2025 | Leviticus Partners LP | 13G/A | 8.1% | 3.60M | SEC |
| 6 | May 15, 2025 | Harvey Partners, LLC | 13G/A | 5.0% | 2.19M | SEC |
| 7 | May 14, 2025 | Leviticus Partners LP | 13G/A | 9.8% | 4.33M | SEC |
| 8 | May 8, 2025 | Weber Capital Management, LLC | 13G/A | 7.3% | 3.20M | SEC |
| 9 | Apr 8, 2025 | Leviticus Partners LP | 13G/A | 8.6% | 3.77M | SEC |
| 10 | Apr 7, 2025 | Punch &Amp; Associates Investment Management, Inc. | 13G/A | 0.1% | 25.6K | SEC |
33 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Harvard Bioscience Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Meros Investment Management, LP | 118.5K | $577.2K |
| 2 | Nano Cap New Millennium Growth Fund L P | 117.5K | $572.2K |
| 3 | Financial Connections Group, Inc. | 30 | $0 |